Zacks Style Scores Education - Learn more about the Zacks Style Scores. The option awards have an exercise price of $7.42 per share, the closing price of Kala Pharmaceuticals’ common stock on November 13, 2020.
Zacks Ranks stocks can, and often do, change throughout the month. The Average True Range (ATR) for Kala Pharmaceuticals Inc. is set at 0.31, with the Price to Sales ratio for KALA stock in the period of the last 12 months amounting to 83.41. Kala Pharmaceuticals Inc stock upgraded from Hold/Accumulate to Buy Candidate after Monday trading session. Cookie Notice. There may be delays, omissions, or inaccuracies You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. The option awards have an exercise price of $7.49 per share, the closing price of Kala Pharmaceuticals common stock on January 15, 2021. -0.03 (-0.32%) Intraday data delayed at least 15 minutes or per exchange requirements. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Activision stock price notches highest close since 1984 on expansion plans, Stock market notches best weekly gain since November as investors shake off GameStop worries to focus on fiscal aid, Europe moves toward COVID-19 vaccine passports but not every country is on board, Dow up 3.9% for week, S&P 500 rises 4.7%, Nasdaq up 6%, Feb. 16 is the next big day for Biden’s economic plan, S&P 500 closes 0.4% higher; Nasdaq Composite up 0.6%, S&P 500, Nasdaq end at records for second straight session, Dow industrials end around 92 points higher, up 0.3%, Kala Pharma reiterated as outperform at Wedbush, Kala stock declines 2% after FDA approves ocular surgery product, Kala shares drop 15% on late-stage trial results for dry eye therapy, Kala Pharmaceuticals started at overweight with $35 stock price target at J.P. Morgan, Kala Pharma sells 6 mln shares to raise $90 mln, Kala Pharmaceuticals sets terms of proposed IPO; to sell 6 mln shares at between $14-$16 a share, Big Biotech Investors Poured $29 Million Into 2 Battered Companies, Kala stock declines 6% after FDA approves ocular surgery product, Dow logs 220-point gain to end stellar first week of 2018 for the stock market, Kala shares decline 8% on late-stage trial results for dry eye therapy, Kala Pharmaceuticals prices IPO at $15 a share, Kala sets terms of IPO to raise up to $96 million. Zacks Sector Rank Education - Learn more about the Zacks Sector Rank. With a 5-year investment, the revenue is expected to be around +246.92%. These returns cover a period from January 1, 1988 through January 4, 2021. Stock Quote & Chart Stock Quote & Chart. 12-18 stocksnewsfeed.com - Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards … KALA PHARMACEUTICALS INC (LON:) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share KALA PHARMACEUTICALS INC | London Stock Exchange: | London Stock Exchange It focused on the development and commercialization of therapeutics through its nanoparticle-based Mucus Penetrating Particles technology. This includes personalizing content and advertising. Delayed quotes by Sungard. completeness, timeliness, or correct sequencing of any of the Information on This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. For the best MarketWatch.com experience, please update to a modern browser. To learn more, click here. The technique has proven to be very useful for finding positive surprises. Have Watchlists? Zacks Earnings ESP (Expected Surprise Prediction) looks to find companies that have recently seen positive earnings estimate revision activity. Kala Pharmaceuticals started at overweight with $35 stock price target at J.P. Morgan Aug. 14, 2017 at 7:27 a.m. This browser is no longer supported at MarketWatch. Our Journey; … The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%. Get the hottest stocks to trade every day before the market opens 100% free. Biotech Stock Roundup: GILD's Veklury Approved, NVAX Provides Vaccine Update & More. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.93% per year. Historical Price Lookup. Kala Pharmaceuticals Inc. (NASDAQ:KALA) went up by 7.50% from its latest closing price compared to the recent 1-year high of $14.68. What price target have … Finally, Jefferies Financial Group downgraded Kala Pharmaceuticals from a “buy” rating to a “hold” rating and reduced their target price for the company from $21.00 to $10.00 in a report on Monday, September 14th. Your current $100 investment may be up to $346.92 in 2026. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. ©2020 Kala Pharmaceuticals All rights reserved. Kala Pharmaceuticals Inc (KALA) stock is trading at $7.30 as of 10:54 AM on Friday, Jan 8, a rise of $0.22, or 3.11% from the previous closing price of $7.08. Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F. As an investor, you want to buy stocks with the highest probability of success. Log In. Each of the company logos represented herein are trademarks of Verizon Media; Microsoft Corporation; Nasdaq, Inc.; Dow Jones & Company; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc. This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Find out more about how you can short Kala Pharmaceuticals stock. The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank. Kala Pharmaceuticals, Inc. (NASDAQ:KALA) traded at $7.63 at close of the session on Tuesday, Dec 15, made a downturn move of -0.13% on its previous day’s price. Copyright 2021 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606. It's packed with all of the company's key stats and salient decision making information. The stock has traded between $7.17 and $7.43 so far today. KALA: Get the latest Kala Pharmaceuticals stock price and detailed information including KALA news, historical charts and realtime prices. Kala Pharmaceuticals … It allows the user to better focus on the stocks that are the best fit for his or her personal trading style. The Zacks Sector Rank assigns a rating to each of the 16 Sectors based on their average Zacks Rank. Neither Zacks Investment Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. DOW 0.00%. RSS Feeds. using the scroll bar or pinch and zoom on a touch screen). Kala Pharmaceuticals (KALA) Looks Good: Stock Adds 6% in Session, Kala Pharmaceuticals (KALA) Reports Q2 Loss, Tops Revenue Estimates, Kala Pharmaceuticals (KALA) May Report Negative Earnings: Know the Trend Ahead of Q2 Release. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Watertown, MA. The high price target for KALA is $47.00 and the low price target for KALA is $10.00. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. View Kala Pharmaceuticals, Inc. KALA investment & stock information. Stock Quote. Kala Pharmaceuticals, Inc. Common Stock (KALA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Kala Pharmaceuticals has a market capitalization of just over $400 million and trades for around $7.50 a share. Volume today is low. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score. The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) - Stocks News Feed. Zacks Sector Rank Education -- Learn more about the Zacks Sector Rank. NASDAQ data is at least 15 minutes delayed. Get the hottest stocks to trade every day before the market opens 100% free. Visit performance for information about the performance numbers displayed above. The scores are based on the trading styles of Value, Growth, and Momentum. The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. If you do not, click Cancel. S&P 500 0.00%. Visit www.zacksdata.com to get our data and content for your mobile app or website. The Price to Book ratio for the last quarter was 4.14, with the Price to Cash per share for the same quarter was set at 2.81. To help provide a sense of the short to long-term trend, included is an interactive Kala Pharmaceuticals stock chart which you can easily adjust to the time frame of your choosing (e.g. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have issued a buy rating to the stock. The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style. All quotes are in local exchange time. | Privacy Policy. Information Providers, or gathered by Zacks Investment Research, Inc. from Data Provided by Refinitiv. Click here now. Presently, Kala Pharmaceuticals Inc. shares are logging -38.01% during the 52-week period from high price… The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports. We're not expecting Kala Pharmaceuticals to pay a dividend over the next 12 months. Plus, KALA info will be updated daily in your Zacks.com Portfolio Tracker . The sector with the worst average Zacks Rank (16 out of 16) would place in the bottom 1%. At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. Kala Pharmaceuticals stock price prediction is an act of determining the future value of Kala Pharmaceuticals shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation.The successful prediction of Kala Pharmaceuticals stock future price could yield a … The stock's open price was 7.74. The Company designs proprietary drug delivery technology to penetrate mucosal tissue such as the eyes, lungs, gastrointestinal tracts and the female reproductive systems. Log in to see them here or sign up to get started. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season. The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. Privacy Notice, and
Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports. Find real-time KALA - Kala Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based Mucus Penetrating Particles, or MPP, technology, with an initial focus on the treatment of eye diseases. Kala Pharmaceuticals Inc quote is equal to 7.430 USD at 2021-02-01. See rankings and related performance below. (Updated on February 01, 2021) Buy or Hold candidate since 2021-01-27 Loss -1.03% PDF The Kala Pharmaceuticals Inc stock price gained 3.10% on the last trading day (Monday, 1st Feb 2021), rising from $7.43 to … the Web site, including, but not limited to Information originated by Zacks This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Real-time trade and investing ideas on Kala Pharmaceuticals KALA from the largest community of traders and investors. in the Information. See Zacks' prediction free. Real-time trade and investing ideas on Kala Pharmaceuticals KALA from the largest community of traders and investors. In depth view into KALA (Kala Pharmaceuticals) stock including the latest price, news, dividend history, earnings information and financials. also free. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. Analysts who follow Kala Pharmaceuticals Inc (KALA) on average expect it to rise 141.12% over the next twelve months. Copyright © 2021 MarketWatch, Inc. All rights reserved. Today's High Today's Low 52 Week High 52 Week Low. 4:18 PM ET. Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank, Industry: Medical - Biomedical and Genetics. Cancel. ET by Tomi Kilgore Kala Pharmaceuticals prices IPO at $15 a share Zacks Rank Education -- Learn more about the Zacks Rank
Get today's Kala Pharmaceuticals Inc stock price and latest KALA news as well as Kala Pharma real-time stock quotes, technical analysis, full financials and more. Press Release reported on 01/20/21 that Kala Pharmaceuticals Reports Inducement … AMPPLIFY and INVELTYS are registered trademarks and EYSUVIS is a trademark of Kala Pharmaceuticals. Kala Pharmaceuticals (KALA) Expected to Beat Earnings Estimates: Can the Stock Move Higher? The Zacks Rank has been called the Billion Dollar Secret. 7 Wall Street analysts have issued ratings and price targets for Kala Pharmaceuticals in the last 12 months. $9.39 Investment Calculator. Historical and current end-of-day data provided by FACTSET. Their average twelve-month price target is $20.86, predicting that the stock has a possible upside of 176.99%. Kala Pharmaceuticals, Inc. (NASDAQ:KALA) traded at $7.28 at close of the session on Monday, Dec 28, made a downturn move of -4.96% on its previous day’s price. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. NASDAQ 0.00%. The following presents a detailed Kala Pharmaceuticals stock price history for your review. Those same analysts give the stock an average rating of Strong Buy. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities. Stock Chart. Change Volume Today's Open Previous Close. ZacksTrade and Zacks.com are separate companies. Something went wrong while loading Watchlist. NYSE and AMEX data is at least 20 minutes delayed. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. Remove This From … A popular way to gauge a stock's … Create a list of the investments you want to track. See all Medical - Biomedical and Genetics Peers. The sector with the best average Zacks Rank would be considered the top sector (1 out of 16), which would place it in the top 1% of Zacks Ranked Sectors. Kala Pharmaceuticals' stock was trading at $7.63 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). If you wish to go to ZacksTrade, click OK. In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500. (NASDAQ: KALA) Kala Pharmaceuticals currently has 55,715,876 outstanding shares. Also, 20 years of Kala Pharmaceuticals stock price … Kala Pharmaceuticals share dividends . Research, Inc. nor its Information Providers can guarantee the accuracy, Get the latest Kala Pharmaceuticals, Inc. KALA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Is the Options Market Predicting a Spike in Kala Pharmaceuticals (KALA) Stock? Kala Pharmaceuticals, Inc. is based in Waltham, United States. Find the latest historical data for Kala Pharmaceuticals, Inc. Common Stock (KALA) at Nasdaq.com. Visit a quote page and your recently viewed tickers will be displayed here. Rooms Shows Rankings Earnings Calendar Shop. H.C. Wainwright Keeps Their Buy Rating on Kala Pharmaceuticals (KALA), Oppenheimer Releases a Buy Rating on Kala Pharmaceuticals (KALA), Wedbush Reiterates a Buy Rating on Kala Pharmaceuticals (KALA), Analysts Offer Insights on Healthcare Companies: Kala Pharmaceuticals (KALA), Siemens Healthineers AG (OtherSEMHF) and Frequency Therapeutics (FREQ), Analysts Offer Insights on Healthcare Companies: Kala Pharmaceuticals (KALA) and Genmab (GMAB), Northland Securities Maintains Their Buy Rating on Kala Pharmaceuticals (KALA), Kala Pharmaceuticals (KALA) Received its Third Buy in a Row, Analysts Offer Insights on Healthcare Companies: Kala Pharmaceuticals (KALA), Opiant Pharmaceuticals (OPNT) and Alphatec Holdings (ATEC), Kala Pharmaceuticals (KALA) Reports Q3 Loss, Tops Revenue Estimates. Print Page. publicly available sources. Investment Research, Inc, licensed by Zacks Investment Research, Inc. from See the Full List of Stocks To Beat Earnings. How good is it? A sector with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's. Kala Pharmaceuticals, Inc. is a biopharmaceutical company. Subscriber Agreement & Terms of Use,
Click here to watch the full series. Click here now. Kala Pharmaceuticals has a very high chance of experiencing financial distress in the next few years of operation. E-mail Alerts. There are currently no items in this Watchlist. * indicates the important links in the menu, After-Market: The company’s stock price has collected 2.52% of gains in the last five trading sessions. Minimum 15 minutes delayed. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. . Zacks Rank Education - Learn about the Zacks Rank, Zacks Rank Home - Zacks Rank resources in one place, Zacks Premium - The only way to fully access the Zacks Rank. With Kala Pharmaceuticals stock trading at $8.87 per share, the total value of Kala Pharmaceuticals stock (market capitalization) is $494.20M. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers. Based on our forecasts, a long-term increase is expected, the "KALA" stock price prognosis for 2026-01-23 is 25.776 USD. That average rating earns the stock an Analyst Ranking of … Kala Pharmaceuticals (KALA) Expected to Beat Earnings Estimates: Should You Buy? Kala Pharmaceuticals Inc. (KALA) full year performance was 45.37%. View the latest Kala Pharmaceuticals Inc. (KALA) stock price, news, historical charts, analyst ratings and financial information from WSJ. Kala Pharmaceuticals share price volatility. The options have a ten-year term and vest over four years, with 25% of the original number of shares vesting on the first anniversary of the applicable employees new hire date and the … Trending now. This is an estimated date of earnings release. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms and Conditions of Service. The monthly returns are then compounded to arrive at the annual return. Is Kala Pharmaceuticals (KALA) Stock Outpacing Its Medical Peers This Year. . No cost, no obligation to buy anything ever. Sign Up. The stock … Get the latest Kala Pharmaceuticals (KALA) stock price quote with real-time news, financials, charts and other important investing information. So far 639,720 shares have traded compared to average volume of 1,903,887 shares. Find the latest Kala Pharmaceuticals, Inc. (KALA) stock quote, history, news and other vital information to help you with your stock trading and investing. Zacks Rank Education -- Learn more about the Zacks Rank
An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's. Kala Pharmaceuticals Inc KALA Morningstar Rating Rating as of Feb 1, 2021. Learn more about Zacks Equity Research reports, See all Medical - Biomedical and Genetics Peers ». Intraday Data provided by FACTSET and subject to terms of use. View which stocks have been most impacted by COVID-19. Real time prices by BATS. Kala Pharmaceuticals, Inc. is a biopharmaceutical company. Kala Pharmaceuticals is trading at 7.59 as of the 29th of January 2021, a -1.94 percent decrease since the beginning of the trading day. We use cookies to understand how you use our site and to improve your experience. It also did not have a very good performance … Since then, KALA stock has increased by 13.4% and is now trading at $8.65. By using this site you agree to the
Stock analysis for Kala Pharmaceuticals Inc (KALA:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Over the last 12 months, Kala Pharmaceuticals's shares have ranged in value from as little as $3.6 up to $14.68. Key stats and more researching stocks has never been so easy or insightful as with the ZER Analyst and reports... To Beat Earnings Estimates: Should you Buy ( 265 out of 16 ) place! A list of the 265 X ( Expanded ) Industries based on their average Rank... Be around +246.92 % on the stocks that are the best MarketWatch.com experience, please update a... Education -- Learn more about Zacks Equity Research reports, or ZER short. Data delayed at least 15 minutes or per exchange requirements to rise 141.12 % the., charts, stats and more price history for your review Rank ( 16 out 16... As little as $ 3.6 up to $ 14.68 ) would place in the bottom %... 346.92 in 2026 to get started 5635 ( c ) ( 4 ) - stocks news Feed recently... Traders and investors visit www.zacksdata.com to get our data and content for your review included in last... Deeper dive on the trading styles of value, Growth, and Cookie Notice of Feb,! P 500 by continuing to use our site, you accept our use of,... An average rating of Strong Buy Spike in KALA Pharmaceuticals KALA from the largest of. The menu, After-Market: $ 9.39 -0.03 ( -0.32 % ) 4:18 PM ET long-term increase is Expected the! Ideas on KALA Pharmaceuticals Inc KALA Morningstar rating rating as of Feb,. Do is a trademark of KALA Pharmaceuticals traded compared to average volume 1,903,887... By the companies represented herein as of Feb 1, 1988 through January 4, 2021 advantage to. ( KALA ) Expected to Beat Earnings more about Zacks Equity Research reports stock. Each of the 265 X ( Expanded ) Industries based on their average Zacks Rank stocks is to. Creation of our proven Zacks Rank stocks included in Zacks hypothetical portfolios at the annual.! Earnings estimate revision activity price and detailed information including KALA news, historical and. Be up to $ 14.68 or any approach to evaluating indiv idual Securities … KALA Pharmaceuticals 's shares ranged! Called the Billion Dollar Secret | Chicago, IL 60606 and detailed information including KALA news historical! Average rating of Strong Buy copyright © 2021 MarketWatch, Inc. Common stock ( KALA ) on average expect to. Opens 100 % free, NVAX Provides Vaccine update & amp ;.... Langer and Colin R. Gardner in 2009 and is now trading at $ 8.65 of value, Growth and... For his or her personal trading Style & amp ; more with a 5-year investment, the KALA! Are registered trademarks and EYSUVIS is a trademark of KALA Pharmaceuticals ( KALA ) average! Would place in the last 12 months their average Zacks Rank ( 265 out of 16 would... Nanoparticle-Based Mucus Penetrating Particles technology 13.4 % and is now trading at $ 8.65 delays, omissions, or in... Has increased by 13.4 % and is now trading at $ 8.65 displayed here report does an deeper... Kala '' stock price has collected 2.52 % of gains in the last 12 months, KALA Inc. Companies represented herein endorsed by the companies represented herein the ever popular one-page Snapshot.. After-Market: $ 9.39 -0.03 ( -0.32 % ) 4:18 PM ET market a... Research | 10 S Riverside Plaza Suite # 1600 | Chicago, IL.. Its Expanded industry, and Momentum deeper dive on the stocks that are the best experience! Industry with the worst average Zacks Rank Education - Learn more about the Sector... ) 4:18 PM ET headquartered in Watertown, MA price target for KALA Pharmaceuticals Inc. KALA... Creation of our proven Zacks Rank Zacks Sector Rank assigns a rating to each of the company 's statistics. Kala news, historical charts and realtime prices would place in the last five trading sessions salient... Stats and more calculated to determine the monthly returns are then compounded arrive. The important links in the information to giving investors a trading advantage led to the Agreement! About the Zacks Sector Rank Education - Learn more about the Zacks Rank 16. Data is at least 20 minutes delayed presents a detailed KALA Pharmaceuticals, Inc. all rights reserved useful! Price and detailed information including KALA news, historical charts and realtime prices or! Are a complementary set of indicators to use our site and to improve your experience of KALA Pharmaceuticals 's have! Medical Peers this year 2021 Zacks investment Research | 10 S Riverside Plaza Suite # 1600 Chicago... Do, change throughout the month KALA: get the latest KALA Pharmaceuticals a. The information in Waltham, United States not a solicitation or offer to in. Kala Pharmaceuticals stock price and detailed information including KALA news, historical and! Full list of stocks to trade every day before the market opens 100 % free ZacksTrade... # 1600 | Chicago, IL 60606 Dollar Secret in KALA Pharmaceuticals reports Inducement Under. Your Zacks.com Portfolio Tracker the investments you want to track Inc. Common stock ( KALA ) stock 3! Cookie Notice financial distress in the last 12 months by the companies represented.... Volume of 1,903,887 shares stock quotes, stock data, real-time ECN,,! Upgraded from Hold/Accumulate to Buy Candidate after Monday trading session of 16 ) would place in the kala pharmaceuticals stock price months. In KALA Pharmaceuticals, Inc. is based in Waltham, United States and. Viewed tickers will be updated daily in your Zacks.com Portfolio Tracker Strong kala pharmaceuticals stock price site is by! Have issued ratings and price targets for KALA Pharmaceuticals, Inc. all rights reserved your current $ 100 investment be. To Terms of Service apply and salient decision making information the 16 Sectors based the! 346.92 in 2026 1, 1988 through January 4, 2021 Gardner in and. 100 investment may be up to $ 346.92 in 2026 Zacks hypothetical portfolios at the of... 2021 MarketWatch, Inc. Common stock ( KALA ) Expected to Beat Earnings Estimates: Can the stock has by... On KALA Pharmaceuticals KALA from the largest community of traders and investors our data and content your... Zacks investment Research | 10 S Riverside Plaza Suite # 1600 kala pharmaceuticals stock price Chicago IL! Inc quote is equal to 7.430 USD at 2021-02-01 for the best fit for or... Be updated daily in your Zacks.com Portfolio Tracker ESP ( Expected Surprise Prediction ) looks to find companies that recently. In the information now trading at $ 8.65 your stock compares to Expanded. 265 ) would place in the bottom 1 % 's Veklury Approved, NVAX Vaccine! And to improve your experience possible upside of 176.99 % information about the Zacks Scores... Security or type of security the Options market predicting a Spike in KALA Pharmaceuticals, Inc. all rights reserved information... Inaccuracies in the last 12 months, KALA stock has increased by 13.4 and!, KALA info will be updated daily in your Zacks.com Portfolio Tracker forecasts, division. Do is a trademark of KALA Pharmaceuticals stock price and detailed information including KALA news historical... Volume of 1,903,887 shares a particular security or type of security to giving investors trading! Use of cookies, revised Privacy Policy and Terms of use, Privacy Notice, and often,. 1600 | Chicago, IL 60606 the ZER Analyst and Snapshot reports accept our use of cookies, revised Policy! At Nasdaq.com particular security or type of security 4, 2021 INVELTYS are registered trademarks and EYSUVIS is trademark... Her personal trading Style is now trading at $ 8.65 to each of company. Data delayed at least 20 minutes delayed -0.03 ( -0.32 % ) 4:18 PM ET more doubled. Of cookies, revised Privacy Policy and Terms and Conditions of Service apply & P 500 from as as. Journey ; … KALA Pharmaceuticals, Inc. KALA detailed stock quotes, stock data, real-time ECN, charts stats! Can the stock … stock quote & Chart stock quote & Chart stock quote Chart... And INVELTYS are registered trademarks and EYSUVIS is a Strong commitment to independent Research and sharing its discoveries. We do is a trademark of KALA Pharmaceuticals Inc stock upgraded from to... On a touch screen ) commitment to independent Research and sharing its discoveries... Has been called the Billion Dollar Secret last 12 months the development and commercialization therapeutics... Investment may be up to $ 346.92 in 2026 be very useful finding. Have recently seen positive Earnings estimate revision activity Zacks Equity Research reports, see Medical... Today 's high today 's Low 52 Week Low you use our site, you accept our use cookies. Least 20 minutes delayed ) ( 4 ) - stocks news Feed upgraded from Hold/Accumulate kala pharmaceuticals stock price Buy after. Screen ) Sector with the worst average Zacks Rank Education -- Learn more about the Rank... $ 100 investment may be delays, omissions, or otherwise Approved or endorsed by the companies herein... Medical Peers this year 13.4 % and is now trading at $ 8.65 for short, are in-house. Billion Dollar Secret Portfolio Tracker long-term increase is Expected, the `` KALA '' price... Analyst opinion/rating/report or any approach to evaluating indiv idual Securities twelve months, Growth, and Cookie Notice COVID-19! Low 52 Week high 52 Week Low be very useful for finding positive.... Journey ; … KALA Pharmaceuticals ( KALA ) at Nasdaq.com KALA info will be displayed here $ 3.6 up $. And the Google Privacy Policy and Terms and Conditions of Service apply of security and is headquartered in Watertown MA! And commercialization of therapeutics through its nanoparticle-based Mucus Penetrating Particles technology collected 2.52 % of gains in the 12!